RT Journal Article
SR Electronic
T1 Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 138
OP 141
VO 24
IS 2
A1 Owaidah, Tarek M.
YR 2003
UL http://smj.org.sa/content/24/2/138.abstract
AB The application of immunotherapy in the treatment of hematological malignancies is relatively new. Donor lymphocyte infusion (DLI) is a form of adaptive cellular therapy where the transfer of cells from immunocompetent donor to patient with cancer who relapsed after bone marrow transplantation results in destruction of the malignant cells. Hereby, we review the concepts, mechanisms, and results of the application of DLI in treatment of some hematological malignancies.